Journal of Diabetes & Metabolism · 2014 · 52 citations · 41 references
PharmacyHealth EducationPharmacoeconomicsCost-benefit AnalysisCost-effectiveness AnalysisHealth EconomicsCost-effectiveness ComparisonDiabetes PreventionEconomic EvaluationHealthcare Cost AnalysisModel-based Economic EvaluationPharmacoeconomic EvaluationBias In Economic EvaluationClinical Evidence ReviewCost-effectiveness Analysis PerspectiveCost-effectiveness Of PreventionEconomic Evidence AnalysisHealth Economic ReviewMethods Of Economic EvaluationPharmacoeconomic Review
Objective: To update current evidence on the cost-effectiveness (CE) of therapeutic education in prediabetes and type 2 diabetes.
41
Onset of NIDDM occurs at Least 4–7 yr Before Clinical Diagnosis
Maureen I Harris, Ronald Klein, Tim Welborn et al. · Diabetes Care · 1992 · 1.3K citations
Milton C. Weinstein, John Hornberger, Magnus Johannesson et al. · Value in Health · 2003 · 1.2K citations · Full text